Analyst picks & changes

Analyst picks & changes

Analyst picks & changes
Company Bank Analyst Coverage Opinion
AtheroGenics (AGIX) Lazard Joel Sendek Price target Buy
Needham Mark Monane New Underperform
Sendek raised his target to $71 from $27 to reflect the value of

Read the full 399 word article

User Sign In